GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Total Non-Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Assets | ₹4,966 Cr | ₹1,877 Cr | ₹1,982 Cr | ₹1,372 Cr | ₹1,240 Cr |
What is the latest Total Non-Current Assets ratio of GLAND PHARMA ?
Year | Total Non-Current Assets |
---|---|
Mar2024 | ₹4,966 Cr |
Mar2023 | ₹1,877 Cr |
Mar2022 | ₹1,982 Cr |
Mar2021 | ₹1,372 Cr |
Mar2020 | ₹1,240 Cr |
How is Total Non-Current Assets of GLAND PHARMA Trending?
Years | Total Non-Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹4,966 Cr | 164.59 | |
Mar2023 | ₹1,877 Cr | -5.29 | |
Mar2022 | ₹1,982 Cr | 44.38 | |
Mar2021 | ₹1,372 Cr | 10.70 | |
Mar2020 | ₹1,240 Cr | - |
Compare Total Non-Current Assets of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹26,001.3 Cr | -3.2% | 6.7% | -8.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,213.0 Cr | 3.9% | -3.2% | 3.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹150,403.0 Cr | 1.8% | -4.5% | 53.9% | Stock Analytics | |
CIPLA | ₹117,415.0 Cr | -0.6% | -0.3% | -2.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹104,791.0 Cr | 1.2% | -3% | 14.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,228.2 Cr | -3% | -9.5% | -11.7% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | -3.2% |
6.7% |
-8.8% |
SENSEX | 0.4% |
-4.9% |
-0.1% |
You may also like the below Video Courses